MedTrace Logo

Nutritional Biomarkers of Sarcopenia

NCT05117112 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-09-25

Study results available
· View outcomes & findings →

Summary

This study proposes to characterize skeletal muscle amino acid kinetics to an EAA challenge, i.e., an oral amino acid tolerance test (OATT), in order to determine the state of muscle health. Analogous to the oral glucose tolerance test (OGTT) used to characterize alterations in glucose metabolism, the proposed OATT represents a potential low-cost solution to classifying patients' skeletal muscle health. The extrapolation of this work is the development of a simple analytical tool that would provide clinicians the ability to discern alterations in muscle amino acid kinetics prior to a loss of function.

Conditions

Interventions

DIETARY_SUPPLEMENT

XS Muscle Multiplier

Distributed by Amway; this product is a powder, sold in a 6.8 ounce (192g) container.

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • David D Church, Ph.D. · University of Arkansas

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-08
Primary Completion
2023-01-12
Completion
2023-01-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05117112 on ClinicalTrials.gov